Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Strahlentherapie|September 1, 1979
[Irradiation prophylaxis of keloids and cicatricial hypertrophies (author's transl)]H Ernst, A Besserer, I FlemmingWilderness & Environmental Medicine|October 1, 2013
Patterns of outdoor recreational injury in northern British ColumbiaFloyd A Besserer, Nadine R CaronMolecular Pharmacology|January 1, 1988
Biochemical pharmacology and DNA-drug interactions by Cl-958, a new antitumor intercalator derived from a series of substituted 2H-[1]benzothiopyrano[4,3,2-cd]indazolesD W Fry, J A BessererCancer Research|December 15, 1988
Characterization of trimetrexate transport in human lymphoblastoid cells and development of impaired influx as a mechanism of resistance to lipophilic antifolatesD W Fry, J A BessererJournal of Cancer Research and Clinical Oncology|January 1, 1993
Low-dose radiation therapy for testicular intraepithelial neoplasiaK P Dieckmann, A Besserer, V LoyCancer Research|August 1, 1984
Transport of the antitumor antibiotic Cl-920 into L1210 leukemia cells by the reduced folate carrier systemD W Fry, J A Besserer, T J BoritzkiCancer Letters|June 1, 1986
Cross resistance of pleiotropically drug resistant P338 leukemia cells to the lipophilic antifolates trimetrexate and BW 301UW D Klohs, R W Steinkampf, J A Besserer, et al.Biochemical Pharmacology|October 1, 1985
In vitro DNA strand scission and inhibition of nucleic acid synthesis in L1210 leukemia cells by a new class of DNA complexers, the anthra[1,9-cd]pyrazol-6(2H)-ones (anthrapyrazoles)D W Fry, T J Boritzki, J A Besserer, et al.Biochemical Pharmacology|November 1, 1988
Inhibition of type II topoisomerase by fostriecinT J Boritzki, T S Wolfard, J A Besserer, et al.Pageof 2